Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.095 USD | -1.09% | -5.54% | -83.54% |
05-14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
05-10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- MarketScreener Strategies